http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2017016655-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_675375ae4f084b4875d36afff6059afd
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-30
filingDate 2016-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80f5a9975a6a0ad0f0d51b113a312c4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9b66fdaba92325eed819ce1f8a6c467
publicationDate 2018-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2017016655-A
titleOfInvention OPHTHALMIC FORMULATIONS OF THYROSINE KINASE INHIBITORS, METHODS OF USE OF THE SAME AND METHODS OF PREPARATION OF THE SAME.
abstract Ophthalmic formulations containing tyrosine kinase inhibitors are described, such as Nintedanib, Axitinib, Sorafenib and Pazopanib; ophthalmic formulations may contain microparticles or nanoparticles of the tyrosine kinase inhibitor; Methods for using ophthalmic formulations to treat ocular surface diseases, such as pterygium, including recurrent pterygium and hyperemia associated with pterygium are also described.
priorityDate 2015-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10113978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419592141
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6450551
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135423438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419540924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406972292

Total number of triples: 34.